16.7
速率程序化药物递送系统,即DDS,旨在以特定且可控的速率释放药物,以维持稳定的治疗浓度。这些系统根据其释放机制进行分类,包括溶出控制型DDS、扩散控制型DDS,以及溶出–扩散联合控制型DDS。
在溶出控制型DDS中,释放速率取决于药物本身或其周围基质的缓慢溶出。一些本身溶出速率较慢的药物,如灰黄霉素…
程序控速型药物递送系统采用聚合物基质、储库、渗透泵和微芯片系统等方法,以可控速率释放药物。程序控速型药物递送系统包含多种类型。
在溶出控制型药物递送系统(DDS)中,药物释放速率取决于药物或周围基质的缓慢溶出。
溶解速率较慢的药物会逐渐溶解,而另一些药物在接触胃肠道液体后会转化为溶解较慢的形式。
另一种方法是将药物嵌入缓慢溶解的基质中,或用缓慢溶解的材料包覆,以控制液体渗透。
在扩散控制型药物递送系统(DDS)中,药物释放速率取决于溶解的药物分子通过一个非降解性且可吸水膨胀或不溶于水的限速元件的扩散过程。
黄原胶、羟丙基甲基纤维素(HPMC)和乙基纤维素等聚合物常用于这些药物递送系统中。
溶解和扩散控制型药物递送系统结合了这两种机制,利用能够通过溶解和扩散来调控药物释放速率的材料。
View the full transcript and gain access to JoVE Core videos
Q1: What are the main types of rate-programmed drug delivery systems?
Rate-programmed drug delivery systems include dissolution-controlled, diffusion-controlled, and combined dissolution-diffusion-controlled approaches. Dissolution-controlled systems rely on slow drug or matrix dissolution. Diffusion-controlled systems use non-degradable barriers that regulate drug diffusion. Combined systems integrate both mechanisms to achieve precise, sustained release and maintain consistent therapeutic levels.
Q2: How does dissolution control drug release in modified release systems?
In dissolution-controlled systems, release rate depends on how slowly the drug or surrounding matrix dissolves. Drugs with inherently slow dissolution rates, like griseofulvin and digoxin, dissolve gradually in gastrointestinal fluids. Some drugs transform into slower-dissolving forms upon contact with GI fluids, extending release. Embedding drugs in slowly dissolving matrices or coating them with slow-dissolving materials further regulates fluid penetration and delays drug release.
Q3: What role do polymers play in diffusion-controlled drug delivery?
Polymers form rate-controlling barriers that regulate drug diffusion without dissolving or degrading. Water-swellable polymers like xanthan gum, HPMC, and alginates absorb fluid while maintaining structural integrity. Water-insoluble polymers such as ethyl cellulose and polymethacrylates create stable diffusion barriers. These materials ensure steady, predictable drug release by controlling how dissolved drug molecules pass through the barrier.
Q4: How do combined dissolution-diffusion systems improve drug delivery control?
Combined dissolution-diffusion-controlled systems integrate slow-dissolving coatings with diffusion barriers to enhance release precision. By utilizing materials that influence both dissolution and diffusion processes simultaneously, these hybrid designs achieve superior control over drug release rates. This dual-mechanism approach provides flexible solutions for medications requiring prolonged absorption, improving patient compliance and treatment efficiency.
Q5: What is the difference between water-swellable and water-insoluble polymers in drug delivery?
Water-swellable polymers like xanthan gum and HPMC absorb gastrointestinal fluids while remaining structurally intact, allowing controlled drug diffusion through the swollen matrix. Water-insoluble polymers such as ethyl cellulose and polymethacrylates do not absorb fluid but form impermeable barriers that regulate drug passage. Both types maintain non-degradable, stable structures throughout drug delivery, ensuring predictable release kinetics.
Q6: Why are rate-programmed systems beneficial for patient compliance?
Rate-programmed systems maintain consistent therapeutic drug levels by releasing medication at controlled rates, reducing dosing frequency and improving patient compliance. By providing prolonged absorption and sustained therapeutic effects, these systems enhance treatment efficiency and reduce the burden of frequent medication administration. This controlled approach ensures better therapeutic outcomes while minimizing side effects associated with fluctuating drug concentrations.
Q7: How do drugs like ferrous sulfate behave differently in dissolution-controlled systems?
Ferrous sulfate transforms into a slower-dissolving form when exposed to gastrointestinal fluids, extending its release profile in dissolution-controlled systems. This chemical transformation upon contact with GI fluids naturally slows drug dissolution, allowing gradual absorption. Such drugs demonstrate how dissolution-controlled systems can exploit inherent drug properties to achieve sustained release without requiring additional matrix or coating materials.